NCT02574663 2019-10-02TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid TumorsTG Therapeutics, Inc.Phase 1 Completed66 enrolled